• Atrial septal defect ( ASD ) closure
• Left atrial appendage occlusion ( LAAO )
• Minimally invasive surgical heart valve repair or replacement
• Minimally invasive surgical repair of structural heart defects
• Minimally invasive tricuspid valve repair
• Patent foramen ovale ( PFO ) catheter repair
• Percutaneous tricuspid valve repair
• Transcatheter aortic valve replacement – minimally invasive ( TAVR )
• Transcatheter mitral valve repair – minimally invasive ( TMVR )
• Transcatheter pulmonic valve replacement
3.63
0.90
30
Baylor Scott & White Heart and Vascular Hospital — Dallas | Interventional Cardiology
Structural heart disease program procedures include :
• Atrial septal defect ( ASD ) closure
• Left atrial appendage occlusion ( LAAO )
• Minimally invasive surgical heart valve repair or replacement
• Minimally invasive surgical repair of structural heart defects
• Minimally invasive tricuspid valve repair
• Patent foramen ovale ( PFO ) catheter repair
• Percutaneous tricuspid valve repair
• Transcatheter aortic valve replacement – minimally invasive ( TAVR )
• Transcatheter mitral valve repair – minimally invasive ( TMVR )
• Transcatheter pulmonic valve replacement
For more information about the structural heart disease program or Center for Valve Disorders , please call 214.820.3604 .
Percutaneous coronary intervention
Percutaneous coronary intervention ( PCI ) also known as coronary angioplasty and stenting , is a mainstay of the cardiac catheterization department at Baylor Scott & White Heart and Vascular Hospital – Dallas . Quality and safety metrics related to PCI are analyzed , reported to registries frequently and benchmarks from the National Cardiovascular Database and Registry ( NCDR ) are noted .
Metric performance
BETTER than 90th percentile
In-hospital risk standardized mortality ( All AMI patients )
3.63
My Hospital R4Q Performance
Composite : Major episode events ( all patients )
0.90
My Hospital R4Q Performance
In fiscal year 2024 , the NCDR ’ s published data through Q2 2024 ( rolling 4 quarters ) indicated the following information noted in the table .
Acute myocardial infarction ( AMI ) performance
AMI Performance
Overall AMI performance composite
Overall defectfree care **
STEMI performance composite
NSTEMI performance composite
Discharge AMI performance composite
Acute AMI performance composite
3.5
0
10th 6.34
4 4.5 5 5.5 6 6.5
25th 5.49
US Registry * 75th percentile
50th 4.90
BSWHVH - DALLAS
98.2 % 99.2 %
88.1 % 94.8 %
98.8 % 99.3 %
98.1 % 99.0 %
98.3 % 99.1 %
98.5 % 99.4 %
75th 4.43
Better , same , worse than US Registry 75th percentile
Better
90th
4.07 US Hospital R4Q Performance Distribution for 2023Q4
10th 11.00
2 4 6 8 10 12
25th 7.80
50th 5.10
75th 2.80
90th 1.30
US Hospital R4Q Performance Distribution for 2023Q4
Source : R4Q 2024Q2 National Cardiovascular Database and Registry ( NCDR ) for Baylor Scott & White Heart and Vascular Hospital – Dallas . * Source : R4Q through 2022 Q1 published information . ** Defect-free care includes beta blocker prescribed at discharge , ACE-I or ARB for LVSD at discharge , aspirin at arrival and at discharge and cardiac rehabilitation among other criteria .